Week in Review
A federal judge rules that Texas cannot prosecute organizations that facilitate abortion access, the DEA proposes rules expanding telemedicine care, and more…
New NCAA Rules Leave Foreign Student-Athletes Behind
Scholars argue that foreign student-athletes must now choose between earning money and keeping their immigration status.
FDA, Not a Federal Judge, Should Decide on Abortion Drugs
Anti-abortion advocates take aim at FDA approval and regulation of the abortion drug mifepristone, threatening access nationwide.
Is Your Phone a Medical Device?
Scholar argues that Congress and FDA should treat risky clinical artificial intelligence tools as medical devices.
FDA Advances Program for Real-World Evidence
FDA’s approach to evidence-based decision-making may not be addressed to the right people.
Underrepresented, Overmedicated, and Misdiagnosed
Experts contend that FDA clinical trials fail to ensure adequate consideration of women’s health needs.
Week in Review
HHS proposes drug pricing reforms, DHS proposes rule to deter illegal border crossings, and more…
Building Disaster Resilience in Rural Communities
Report outlines why rural communities susceptible to natural disasters need more federal resources.
Tax Tax Revolution
Scholars argue that implementing a global minimum tax would help solve the tax competition issue.
Expanding FDA Incentives to Boost Diversity in Clinical Trials
Exploring FDA’s toolkit for encouraging study sponsors to meet diversity goals.
Virginia Charts a Path Forward on Regulatory Modernization
New agency sets example for state and federal agencies to follow in analyzing regulatory costs and benefits.